NOTALVISION INC.

NotAlVision Inc. is a digital health company specializing in remote patient monitoring services for retinal diseases, particularly age-related macular degeneration (AMD). The company develops home-based diagnostic devices operated by patients and AI-enabled data analysis platforms to extend eye disease management from traditional clinic settings into patients' homes. NotAlVision's platform addresses the unmet diagnostic need in ophthalmology by enabling real-time, automated analysis of patient testing data through proprietary AI algorithms. The company's approach aims to improve treatment outcomes by facilitating treatment decisions that align with each patient's disease activity timing rather than pre-scheduled clinic appointments. Key clinical focus areas include early detection of dry AMD progression to wet AMD, improving real-world wet AMD treatment outcomes, and optimizing treatment timing to reduce under-treatment. The platform connects patients and physicians 24/7 through a monitoring center and includes a suite of patient-operated home-based diagnostic devices. NotAlVision targets ophthalmology practices and retinal specialists seeking to improve patient engagement, diagnostic accuracy, and clinical outcomes in AMD management. The company combines precision medicine principles with telehealth capabilities to address the acute onset and unpredictable nature of retinal disease progression.